Sabadell - Laboratorios Farmaceuticos Rovi S.A. (ROVI) ROVI: ANUNCIA UN NUEVO CONTRATO DE FABRICACIÓN PARA TERCEROS - CDMO (ANÁLISIS BANCO SABADELL)

Report

Sabadell

Luis Arredondo

EUR 50.00 For Business Accounts Only

ROVI: ANUNCIA UN NUEVO CONTRATO DE FABRICACIÓN PARA TERCEROS - CDMO (ANÁLISIS BANCO SABADELL)

Acaba de anunciar que ha firmado un acuerdo para la fabricación de jeringas precargadas en sus instalaciones con una compañía farmacéutica global.

25/04/2024 1 ES

Underlying

Laboratorios Farmaceuticos Rovi S.A.

Laboratorios Farmaceuticos Rovi is engaged in the sale of its own pharmaceutical products and the distribution of other products for which it holds licenses granted by other laboratories for specific periods, in accordance with the terms and conditions contained in the agreements entered into with said laboratories.

See profile

ES0157261019 Madrid Stock Exchange Spain

Provider

Sabadell

See profile

Analysts

Luis Arredondo

Other Reports on these Companies

Oddo BHF

ODDO BHF Small & MIDCAP MORNING NEWS - 04/26/2024 Date Performance since listing Date Performance since listing

Deutz is a leading non-captive engine manufacturer for a wide range of customer industries with a strong and very well-known brand. The company will enter a profitable growth period soon (CAGR 2023-26e sales 8%, EPS 18%). We initiate coverage with an Outperform rating and a target price of € 7.9, reflecting >40% upside from here. - ...

April 26, 2024 April 26, 2024 1 EN

Oddo BHF

ODDO BHF Small & MIDCAP MORNING NEWS - 26/04/2024

April 26, 2024 April 26, 2024 1 FR

Sabadell

IBERIAN DAILY 26 APRIL + 1Q'24 RESULTS. HIGHLIGHTS AND REST OF PREVIEWS (ANÁLISIS BANCO SABADELL)

NEWS SUMMARY: ACCIONA, ACCIONA ENERGÍA, CAF, CELLNEX, FERROVIAL, IBERDROLA, ROVI. At the end of today’s report, and during the entire results season, we will include a presentation with positive and negative results highlights and previews for the 1Q’24 results to be released over the coming days in Spain. Results and macro data drag down stock markets After three straight days of gains, the business results and the macro data in the US led to stock market losses on both sides of the Atlantic. Within the STOXX 600 sectors, most closed with losses (16 of 20), led by Industrials and Chemical...

EUR 100.00

April 26, 2024 April 26, 2024 1 EN

INTESA SANPAOLO: RDOS. 1T’24 (ANÁLISIS BANCO SABADELL)

Rdos. 1T'24 vs 1T'23: M. Intereses: 3.932 M euros (+20,8% vs +19,9% BS(e) y +20,5% consenso); M. Bruto: 6.732 M euros (+11,1% vs +8,4% BS(e) y +9,2% consenso); M. Neto: 4.162 M euros (+18,2% vs +9,8% BS(e) y +11,8% consenso); BDI: 2.301 M euros (+17,6% vs +13,4% BS(e) y n/a consenso). Rdos. 1T'24 vs 4T'23: M. Intereses: 3.932 M euros (-1,6% vs -2,4% BS(e) y -1,9% consenso); M. Bruto: 6.732 M euros (+5,6% vs +3,0% BS(e) y +3,8% consenso); M. Neto: 4.162 M euros (+43,3% vs +33,1% BS(e) y +35,6% consenso); BDI: 2.301 M euros (+43,6% vs +38,5% BS(e) y n/a consenso).

EUR 100.00

May 3, 2024 May 3, 2024 1 ES

Maria Paz Ojeda

Maria Paz Ojeda

SOCIÉTÉ GÉNÉRALE: RDOS. 1T’24 (ANÁLISIS BANCO SABADELL)

Rdos. 1T'24 vs 1T'23: M. Bruto: 6.645 M euros (-0,4% vs n/a BS(e) y -4,1% consenso); M. Neto: 1.665 M euros (+3,2% vs n/a BS(e) y -14,5% consenso); BDI: 680,0 M euros (-21,7% vs n/a BS(e) y -44,9% consenso). Rdos. 1T'24 vs 4T'23: M. Bruto: 6.645 M euros (+11,5% vs n/a BS(e) y +7,4% consenso); M. Neto: 1.665 M euros (+29,0% vs n/a BS(e) y +6,9% consenso); BDI: 680,0 M euros (+58,1% en 4T'23 vs n/a BS(e) y +11,2% consenso).

EUR 100.00

May 3, 2024 May 3, 2024 1 ES

Maria Paz Ojeda

Maria Paz Ojeda

AXA: VENTAS 1T’24 (ANÁLISIS BANCO SABADELL)

Ventas 1T'24 vs 1T'23: Ingresos total grupo: 33.972 M euros (+6,8% vs +4,7% BS(e) y +6,1% consenso); No Vida: 19.754 M euros (+6,5% vs +4,7% BS(e) y +5,5% consenso); Vida: 9.014 M euros (+7,4% vs +4,2% BS(e) y +7,4% consenso); Salud: 9.014 M euros (+9,5% vs +6,0% BS(e) y +6,2% consenso); Gestión de activos: 385 M euros (2,7% vs 3,2% BS(e) y 0,0% de consenso).

EUR 100.00

May 3, 2024 May 3, 2024 1 ES

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

ROVI: ANUNCIA UN NUEVO CONTRATO DE FABRICACIÓN PARA TERCEROS - CDMO (ANÁLISIS BANCO SABADELL)

ODDO BHF Small & MIDCAP MORNING NEWS - 04/26/2024 Date Performance since listing Date Performance since listing

ODDO BHF Small & MIDCAP MORNING NEWS - 26/04/2024

IBERIAN DAILY 26 APRIL + 1Q'24 RESULTS. HIGHLIGHTS AND REST OF PREVIEWS (ANÁLISIS BANCO SABADELL)

INTESA SANPAOLO: RDOS. 1T’24 (ANÁLISIS BANCO SABADELL)

SOCIÉTÉ GÉNÉRALE: RDOS. 1T’24 (ANÁLISIS BANCO SABADELL)

AXA: VENTAS 1T’24 (ANÁLISIS BANCO SABADELL)

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe